Maeda Y - Search Results

1

Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center.

Okuma Y, Hosomi Y, Watanabe K, Yamada Y, Horio H, Maeda Y, Okamura T, Hishima T. Okuma Y, et al. Among authors: maeda y. BMC Cancer. 2014 May 20;14:349. doi: 10.1186/1471-2407-14-349. BMC Cancer. 2014. PMID: 24885581 Free PMC article.

2

Clinical outcomes with chemotherapy for advanced thymic carcinoma.

Okuma Y, Hosomi Y, Takagi Y, Sasaki E, Hishima T, Maeda Y, Shibuya M, Okamura T. Okuma Y, et al. Among authors: maeda y. Lung Cancer. 2013 Apr;80(1):75-80. doi: 10.1016/j.lungcan.2012.12.012. Epub 2013 Jan 11. Lung Cancer. 2013. PMID: 23313005 Free article.

3

The potency of curative-intent treatment for advanced thymic carcinoma.

Okuma Y, Horio H, Hosomi Y, Watanabe K, Maeda Y, Okamura T, Hishima T. Okuma Y, et al. Among authors: maeda y. Lung Cancer. 2014 May;84(2):175-81. doi: 10.1016/j.lungcan.2014.02.012. Epub 2014 Mar 2. Lung Cancer. 2014. PMID: 24646831

4

Response to cytotoxic chemotherapy in patients previously treated with palliative-intent chemotherapy for advanced thymic carcinoma.

Okuma Y, Hosomi Y, Takahashi S, Maeda Y, Okamura T, Hishima T. Okuma Y, et al. Among authors: maeda y. Clin Lung Cancer. 2015 May;16(3):221-7. doi: 10.1016/j.cllc.2014.10.006. Epub 2014 Oct 31. Clin Lung Cancer. 2015. PMID: 25468802

5

[A case of small cell carcinoma arising in submandibular gland].

Miyamoto S, Maeda Y, Hishima T, Sasaki T. Miyamoto S, et al. Among authors: maeda y. Gan To Kagaku Ryoho. 2010 Sep;37(9):1767-70. Gan To Kagaku Ryoho. 2010. PMID: 20841943 Review. Japanese.

6

[Case of higher efficacy by chemoradiotherapy for anal canal cancer from left cervix metastases to lymph nodes].

Miyamoto S, Maeda Y, Hishima T, Sasaki T. Miyamoto S, et al. Among authors: maeda y. Gan To Kagaku Ryoho. 2009 Feb;36(2):329-32. Gan To Kagaku Ryoho. 2009. PMID: 19223758 Japanese.

7

Central nervous system relapse in patients with diffuse large B cell lymphoma: analysis of the risk factors and proposal of a new prognostic model.

Kanemasa Y, Shimoyama T, Sasaki Y, Tamura M, Sawada T, Omuro Y, Hishima T, Maeda Y. Kanemasa Y, et al. Among authors: maeda y. Ann Hematol. 2016 Oct;95(10):1661-9. doi: 10.1007/s00277-016-2744-5. Epub 2016 Jul 2. Ann Hematol. 2016. PMID: 27370993

8

[Two cases of stomach primary diffuse large B cell lymphoma remitted by Helicobacter pylori eradication therapy].

Miyamoto S, Okamoto R, Maeda Y, Hishima T, Sasaki T. Miyamoto S, et al. Among authors: maeda y. Gan To Kagaku Ryoho. 2008 Dec;35(13):2437-40. Gan To Kagaku Ryoho. 2008. PMID: 19098419 Japanese.

9

Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphoma.

Kanemasa Y, Shimoyama T, Sasaki Y, Tamura M, Sawada T, Omuro Y, Hishima T, Maeda Y. Kanemasa Y, et al. Among authors: maeda y. Hematol Oncol. 2017 Dec;35(4):440-446. doi: 10.1002/hon.2312. Epub 2016 May 30. Hematol Oncol. 2017. PMID: 27238634

10

The impacts of initial and relative dose intensity of R-CHOP on outcomes of elderly patients with diffuse large B-cell lymphoma.

Kanemasa Y, Shimoyama T, Sasaki Y, Tamura M, Sawada T, Omuro Y, Hishima T, Maeda Y. Kanemasa Y, et al. Among authors: maeda y. Leuk Lymphoma. 2017 Mar;58(3):736-739. doi: 10.1080/10428194.2016.1211279. Epub 2016 Aug 11. Leuk Lymphoma. 2017. PMID: 27686739 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,752 results

Search Page

Filters